Potential use of lurasidone for the treatment of bipolar psychosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Potential use of lurasidone for the treatment of bipolar psychosis

Published:2015-01-30 Issue:4 Volume:24 Page:575-584
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Carta Mauro Giovanni¹,Moro Maria Francesca¹,Nardi Antonio E²,Calabrese Joseph R³

Affiliation:

1. 1University of Cagliari, Department of Public Health, Clinical and Molecular Medicine, Cagliari, Italy

2. 2Federal University of Rio de Janeiro, National Academy of Medicine, Medical School - Institute of Psychiatry, Rio de Janeiro, 22410-003, Brazil

3. 3Mood Disorders Program Case Western Reserve School of Medicine, Cleveland, OH 44106, USA

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/13543784.2015.1009976

Reference67 articles.

1. Lurasidone for the treatment of acutely psychotic patients with schizophrenia: A 6-week, randomized, placebo-controlled study

2. Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study

3. Efficacy and safety of lurasidone 80mg/day and 160mg/day in the treatment of schizophrenia: A randomized, double-blind, placebo- and active-controlled trial

4. Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic

5. Long-term safety and tolerability of lurasidone in schizophrenia

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews;BioMed Research International;2017

2. Enhanced dissolution and oral bioavailability of lurasidone hydrochloride nanosuspensions prepared by antisolvent precipitation–ultrasonication method;RSC Advances;2016

3. Lurasidone and fluoxetine reduce novelty-induced hypophagia and NMDA receptor subunit and PSD-95 expression in mouse brain;European Neuropsychopharmacology;2015-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3